Keros Therapeutics, Inc. (KROS)

Keros Therapeutics Revenue

Keros Therapeutics had revenue of $388.00K in the quarter ending September 30, 2024, with 4,750.00% growth. This brings the company's revenue in the last twelve months to $651.00K, up 8,037.50% year-over-year. In the year 2023, Keros Therapeutics had annual revenue of $151.00K.

• Revenue (ttm): $651.00K
• Revenue Growth: +8,037.50%
• P/S Ratio: 685.70
• Revenue / Employee: $4,787
• Employees: 136
• Market Cap: 446.39M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	151.00K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	20.10M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	10.00M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.